Research by Wang et al further emphasized that XYDN effectively treats cholestasis-related jaundice and increases SOD enzyme activity in the liver, thereby boosting hepatocyte antioxidative capacity, scavenging free radicals, and preventing liver fibrosis. This evidence concerns the gene SOD1 and Hepatic fibrosis.